<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39377086</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>09</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2312-0541</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><Issue>5</Issue><PubDate><Year>2024</Year><Month>Sep</Month></PubDate></JournalIssue><Title>ERJ open research</Title><ISOAbbreviation>ERJ Open Res</ISOAbbreviation></Journal><ArticleTitle>A new phenotype of patients with post-COVID-19 condition is characterised by a pattern of complex ventilatory dysfunction, neuromuscular disturbance and fatigue symptoms.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">01027-2023</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1183/23120541.01027-2023</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Patients with post-COVID-19 condition frequently suffer from chronic dyspnoea. The causes and mechanism for dyspnoea in these patients without evidence of structural lung disease are unclear.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Patients treated for COVID-19 at Charité University Hospital in Berlin received pulmonary function testing including respiratory muscle strength tests and completed health-related quality-of-life questionnaires during follow-up. Patients with post-COVID-19 condition during outpatient follow-up with fatigue and exertional intolerance (PCF) were compared to patients with post-COVID-19 condition with evidence of chronic pulmonary sequelae (post-COVID-19 restriction (PCR)) as well as to patients without post-COVID-19 condition (NCF).</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">A total of 170 patients presented for follow-up. 36 participants met criteria for PCF, 28 for PCR and 24 for NCF. PCF patients reported dyspnoea in 63.8%. % predicted value of respiratory muscle strength (median (IQR)) was reduced in PCF (55.8 (41.5-75.9)) compared to NCF and PCR (70.6 (66.3-88.9) and 76.8 (63.6-102.2), respectively; p=0.011). A pattern of reduced forced vital capacity (FVC), but normal total lung capacity (TLC), termed complex ventilatory dysfunction defined as TLC - FVC &gt;10% predicted was observed and occurred more frequently in PCF (88.9%) compared to NCF and PCR (29.1% and 25.0%, respectively; p&lt;0.001).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Dyspnoea in PCF is characterised by reduced respiratory muscle strength and complex ventilatory dysfunction indicating neuromuscular disturbance as a distinct phenotype among patients with post-COVID-19 condition. These observations could be a starting point for developing personalised rehabilitation concepts.</AbstractText><CopyrightInformation>Copyright ©The authors 2024.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Steinbeis</LastName><ForeName>Fridolin</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Infectious Diseases, Respiratory Medicine and Critical Care, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kedor</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Institute of Medical Immunology, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meyer</LastName><ForeName>Hans-Jakob</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Infectious Diseases, Respiratory Medicine and Critical Care, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thibeault</LastName><ForeName>Charlotte</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Infectious Diseases, Respiratory Medicine and Critical Care, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mittermaier</LastName><ForeName>Mirja</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Infectious Diseases, Respiratory Medicine and Critical Care, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Knape</LastName><ForeName>Philipp</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Infectious Diseases, Respiratory Medicine and Critical Care, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahrens</LastName><ForeName>Katharina</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Infectious Diseases, Respiratory Medicine and Critical Care, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rotter</LastName><ForeName>Gabriele</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Social Medicine, Epidemiology and Health Economics, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Temmesfeld-Wollbrück</LastName><ForeName>Bettina</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Infectious Diseases, Respiratory Medicine and Critical Care, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sander</LastName><ForeName>Leif Erik</ForeName><Initials>LE</Initials><AffiliationInfo><Affiliation>Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Infectious Diseases, Respiratory Medicine and Critical Care, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Lung Research (DZL), Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kurth</LastName><ForeName>Florian</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-3807-473X</Identifier><AffiliationInfo><Affiliation>Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Infectious Diseases, Respiratory Medicine and Critical Care, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine I, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Witzenrath</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Infectious Diseases, Respiratory Medicine and Critical Care, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Lung Research (DZL), Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scheibenbogen</LastName><ForeName>Carmen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Institute of Medical Immunology, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zoller</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-9797-1692</Identifier><AffiliationInfo><Affiliation>Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Infectious Diseases, Respiratory Medicine and Critical Care, Berlin, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>ERJ Open Res</MedlineTA><NlmUniqueID>101671641</NlmUniqueID><ISSNLinking>2312-0541</ISSNLinking></MedlineJournalInfo><CoiStatement>Conflict of interest: M. Witzenrath received funding for research from Deutsche Forschungsgemeinschaft, Bundesministerium für Bildung und Forschung, Deutsche Gesellschaft für Pneumologie, European Respiratory Society, Marie Curie Foundation, Else Kröner Fresenius Stiftung, CAPNETZ Stiftung, International Max Planck Research School, Actelion, Bayer Health Care, Biotest, Boehringer Ingelheim, Noxxon, Pantherna, Quark Pharma, Silence Therapeutics, Takeda Pharma, Vaxxilon, and for lectures and advisory from Actelion, Alexion, Aptarion, Astra Zeneca, Bayer Health Care, Berlin Chemie, Biotest, Boehringer Ingelheim, Chiesi, GlaxoSmithKline, Insmed, Novartis, Teva and Vaxxilon. T. Zoller received funding for research from Bundesministerium für Bildung und Forschung, Else Kröner Fresenius Stiftung and Gesellschaft für Internationale Zusammenarbeit. The remaining authors have nothing to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>5</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>8</Day><Hour>10</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>8</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>8</Day><Hour>4</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39377086</ArticleId><ArticleId IdType="pmc">PMC11456967</ArticleId><ArticleId IdType="doi">10.1183/23120541.01027-2023</ArticleId><ArticleId IdType="pii">01027-2023</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis 2020; 20: 533–534. doi:10.1016/S1473-3099(20)30120-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30120-1</ArticleId><ArticleId IdType="pmc">PMC7159018</ArticleId><ArticleId IdType="pubmed">32087114</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta A, Madhavan MV, Sehgal K, et al. . Extrapulmonary manifestations of COVID-19. Nat Med 2020; 26: 1017–1032. doi:10.1038/s41591-020-0968-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0968-3</ArticleId><ArticleId IdType="pubmed">32651579</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain U. Effect of COVID-19 on the organs. Cureus 2020; 12: e9540.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7470660</ArticleId><ArticleId IdType="pubmed">32905500</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, et al. . A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis 2022; 22: e102–e107. doi:10.1016/S1473-3099(21)00703-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah W, Hillman T, Playford ED, et al. . Managing the long term effects of covid-19: summary of NICE, SIGN, and RCGP rapid guideline. BMJ 2021; 372: n136. doi:10.1136/bmj.n136</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n136</ArticleId><ArticleId IdType="pubmed">33483331</ArticleId></ArticleIdList></Reference><Reference><Citation>Global Burden of Disease Long COVID Collaborators , Wulf Hanson S, Abbafati C, et al. . Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021. JAMA 2022; 328: 1604–1615. doi:10.1001/jama.2022.18931</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.18931</ArticleId><ArticleId IdType="pmc">PMC9552043</ArticleId><ArticleId IdType="pubmed">36215063</ArticleId></ArticleIdList></Reference><Reference><Citation>Munblit D, O'Hara ME, Akrami A, et al. . Long COVID: aiming for a consensus. Lancet Respir Med 2022; 10: 632–634. doi:10.1016/S2213-2600(22)00135-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00135-7</ArticleId><ArticleId IdType="pmc">PMC9067938</ArticleId><ArticleId IdType="pubmed">35525253</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, et al. . Post-acute COVID-19 syndrome. Nat Med 2021; 27: 601–615. doi:10.1038/s41591-021-01283-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang N, Li D, Wang X, et al. . Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost 2020; 18: 844–847. doi:10.1111/jth.14768</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14768</ArticleId><ArticleId IdType="pmc">PMC7166509</ArticleId><ArticleId IdType="pubmed">32073213</ArticleId></ArticleIdList></Reference><Reference><Citation>Sungnak W, Huang N, Becavin C, et al. . SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nat Med 2020; 26: 681–687. doi:10.1038/s41591-020-0868-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0868-6</ArticleId><ArticleId IdType="pmc">PMC8637938</ArticleId><ArticleId IdType="pubmed">32327758</ArticleId></ArticleIdList></Reference><Reference><Citation>McElvaney OJ, McEvoy NL, McElvaney OF, et al. . Characterization of the inflammatory response to severe COVID-19 illness. Am J Respir Crit Care Med 2020; 202: 812–821. doi:10.1164/rccm.202005-1583OC</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202005-1583OC</ArticleId><ArticleId IdType="pmc">PMC7491404</ArticleId><ArticleId IdType="pubmed">32584597</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, et al. . 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet 2021; 397: 220–232. doi:10.1016/S0140-6736(20)32656-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinbeis F, Knape P, Mittermaier M, et al. . Functional limitations 12 months after SARS-CoV-2 infection correlate with initial disease severity: an observational study of cardiopulmonary exercise capacity testing in COVID-19 convalescents. Respir Med 2022; 202: 106968. doi:10.1016/j.rmed.2022.106968</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2022.106968</ArticleId><ArticleId IdType="pmc">PMC9420203</ArticleId><ArticleId IdType="pubmed">36081267</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinbeis F, Thibeault C, Doellinger F, et al. . Severity of respiratory failure and computed chest tomography in acute COVID-19 correlates with pulmonary function and respiratory symptoms after infection with SARS-CoV-2: an observational longitudinal study over 12 months. Respir Med 2022; 191: 106709. doi:10.1016/j.rmed.2021.106709</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2021.106709</ArticleId><ArticleId IdType="pmc">PMC8632363</ArticleId><ArticleId IdType="pubmed">34871947</ArticleId></ArticleIdList></Reference><Reference><Citation>Kedor C, Freitag H, Meyer-Arndt L, et al. . A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity. Nat Commun 2022; 13: 5104. doi:10.1038/s41467-022-32507-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-32507-6</ArticleId><ArticleId IdType="pmc">PMC9426365</ArticleId><ArticleId IdType="pubmed">36042189</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurth F, Roennefarth M, Thibeault C, et al. . Studying the pathophysiology of coronavirus disease 2019: a protocol for the Berlin prospective COVID-19 patient cohort (Pa-COVID-19). Infection 2020; 48: 619–626. doi:10.1007/s15010-020-01464-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-020-01464-x</ArticleId><ArticleId IdType="pmc">PMC7293426</ArticleId><ArticleId IdType="pubmed">32535877</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahler DA, Wells CK. Evaluation of clinical methods for rating dyspnea. Chest 1988; 93: 580–586. doi:10.1378/chest.93.3.580</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.93.3.580</ArticleId><ArticleId IdType="pubmed">3342669</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper BG, Stocks J, Hall GL, et al. . The Global Lung Function Initiative (GLI) Network: bringing the world's respiratory reference values together. Breathe (Sheff) 2017; 13: e56–e64. doi:10.1183/20734735.012717</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/20734735.012717</ArticleId><ArticleId IdType="pmc">PMC5607614</ArticleId><ArticleId IdType="pubmed">28955406</ArticleId></ArticleIdList></Reference><Reference><Citation>Quanjer PH, Stanojevic S, Cole TJ, et al. . Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations. Eur Respir J 2012; 40: 1324–1343. doi:10.1183/09031936.00080312</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.00080312</ArticleId><ArticleId IdType="pmc">PMC3786581</ArticleId><ArticleId IdType="pubmed">22743675</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall GL, Filipow N, Ruppel G, et al. . Official ERS technical standard: Global Lung Function Initiative reference values for static lung volumes in individuals of European ancestry. Eur Respir J 2020; 57: 2000289. doi:10.1183/13993003.00289-2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00289-2020</ArticleId><ArticleId IdType="pubmed">33707167</ArticleId></ArticleIdList></Reference><Reference><Citation>Stanojevic S, Graham BL, Cooper BG, et al. . Official ERS technical standards: Global Lung Function Initiative reference values for the carbon monoxide transfer factor for Caucasians. Eur Respir J 2017; 50: 1700010. doi:10.1183/13993003.00010-2017</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00010-2017</ArticleId><ArticleId IdType="pubmed">28893868</ArticleId></ArticleIdList></Reference><Reference><Citation>Laveneziana P, Albuquerque A, Aliverti A, et al. . ERS statement on respiratory muscle testing at rest and during exercise. Eur Respir J 2019; 53: 1801214. doi:10.1183/13993003.01214-2018</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01214-2018</ArticleId><ArticleId IdType="pubmed">30956204</ArticleId></ArticleIdList></Reference><Reference><Citation>Laszlo G. Standardisation of lung function testing: helpful guidance from the ATS/ERS Task Force. Thorax 2006; 61: 744–746. doi:10.1136/thx.2006.061648</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thx.2006.061648</ArticleId><ArticleId IdType="pmc">PMC2117098</ArticleId><ArticleId IdType="pubmed">16936234</ArticleId></ArticleIdList></Reference><Reference><Citation>Clay RD, Iyer VN, Reddy DR, et al. . The “Complex Restrictive” pulmonary function pattern: clinical and radiologic analysis of a common but previously undescribed restrictive pattern. Chest 2017; 152: 1258–1265. doi:10.1016/j.chest.2017.07.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2017.07.009</ArticleId><ArticleId IdType="pubmed">28728932</ArticleId></ArticleIdList></Reference><Reference><Citation>American Thoracic Society/European Respiratory Society . ATS/ERS Statement on respiratory muscle testing. Am J Respir Crit Care Med 2002; 166: 518–624. doi:10.1164/rccm.166.4.518</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.166.4.518</ArticleId><ArticleId IdType="pubmed">12186831</ArticleId></ArticleIdList></Reference><Reference><Citation>Carruthers BM, van de Sande MI, De Meirleir KL, et al. . Myalgic encephalomyelitis: International Consensus Criteria. J Intern Med 2011; 270: 327–338. doi:10.1111/j.1365-2796.2011.02428.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2796.2011.02428.x</ArticleId><ArticleId IdType="pmc">PMC3427890</ArticleId><ArticleId IdType="pubmed">21777306</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001; 16: 606–613. doi:10.1046/j.1525-1497.2001.016009606.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1525-1497.2001.016009606.x</ArticleId><ArticleId IdType="pmc">PMC1495268</ArticleId><ArticleId IdType="pubmed">11556941</ArticleId></ArticleIdList></Reference><Reference><Citation>Blevins CA, Weathers FW, Davis MT, et al. . The posttraumatic stress disorder checklist for DSM-5 (PCL-5): development and initial psychometric evaluation. J Trauma Stress 2015; 28: 489–498. doi:10.1002/jts.22059</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jts.22059</ArticleId><ArticleId IdType="pubmed">26606250</ArticleId></ArticleIdList></Reference><Reference><Citation>Gelpi M, Argentiero J, Jones PW, et al. . A scoring application for the St. George's respiratory questionnaire. Chest 2016; 150: 747–748. doi:10.1016/j.chest.2016.05.029</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2016.05.029</ArticleId><ArticleId IdType="pubmed">27613980</ArticleId></ArticleIdList></Reference><Reference><Citation>Vijayakumar B, Boustani K, Ogger PP, et al. . Immuno-proteomic profiling reveals aberrant immune cell regulation in the airways of individuals with ongoing post-COVID-19 respiratory disease. Immunity 2022; 55: 542–556. doi:10.1016/j.immuni.2022.01.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2022.01.017</ArticleId><ArticleId IdType="pmc">PMC8789571</ArticleId><ArticleId IdType="pubmed">35151371</ArticleId></ArticleIdList></Reference><Reference><Citation>Wendisch D, Dietrich O, Mari T, et al. . SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis. Cell 2021; 184: 6243–6261.e6227. doi:10.1016/j.cell.2021.11.033</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.11.033</ArticleId><ArticleId IdType="pmc">PMC8626230</ArticleId><ArticleId IdType="pubmed">34914922</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagel C, Olschewski H, Sorichter S, et al. . Impairment of inspiratory muscle function after COVID-19. Respiration 2022; 101: 981–989. doi:10.1159/000527361</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000527361</ArticleId><ArticleId IdType="pubmed">36310021</ArticleId></ArticleIdList></Reference><Reference><Citation>Regmi B, Friedrich J, Jorn B, et al. . Diaphragm muscle weakness might explain exertional dyspnea 15 months after hospitalization for COVID-19. Am J Respir Crit Care Med 2023; 207: 1012–1021. doi:10.1164/rccm.202206-1243OC</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202206-1243OC</ArticleId><ArticleId IdType="pmc">PMC10112448</ArticleId><ArticleId IdType="pubmed">36596223</ArticleId></ArticleIdList></Reference><Reference><Citation>Vehar S, Boushra M, Ntiamoah P, et al. . Post-acute sequelae of SARS-CoV-2 infection: caring for the ‘long-haulers’. Cleve Clin J Med 2021; 88: 267–272. doi:10.3949/ccjm.88a.21010</Citation><ArticleIdList><ArticleId IdType="doi">10.3949/ccjm.88a.21010</ArticleId><ArticleId IdType="pubmed">33941600</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramirez-Velez R, Legarra-Gorgonon G, Oscoz-Ochandorena S, et al. . Reduced muscle strength in patients with long-COVID-19 syndrome is mediated by limb muscle mass. J Appl Physiol (1985) 2023; 134: 50–58. doi:10.1152/japplphysiol.00599.2022</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/japplphysiol.00599.2022</ArticleId><ArticleId IdType="pmc">PMC9762963</ArticleId><ArticleId IdType="pubmed">36448687</ArticleId></ArticleIdList></Reference><Reference><Citation>Hennigs JK, Huwe M, Hennigs A, et al. . Respiratory muscle dysfunction in long-COVID patients. Infection 2022; 50: 1391–1397. doi:10.1007/s15010-022-01840-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-022-01840-9</ArticleId><ArticleId IdType="pmc">PMC9108020</ArticleId><ArticleId IdType="pubmed">35570238</ArticleId></ArticleIdList></Reference><Reference><Citation>McNarry MA, Berg RMG, Shelley J, et al. . Inspiratory muscle training enhances recovery post-COVID-19: a randomised controlled trial. Eur Respir J 2022; 60: 2103101. doi:10.1183/13993003.03101-2021</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.03101-2021</ArticleId><ArticleId IdType="pmc">PMC8900538</ArticleId><ArticleId IdType="pubmed">35236727</ArticleId></ArticleIdList></Reference><Reference><Citation>Aschman T, Wyler E, Baum O, et al. . Post-COVID exercise intolerance is associated with capillary alterations and immune dysregulations in skeletal muscles. Acta Neuropathol Commun 2023; 11: 193. doi:10.1186/s40478-023-01662-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-023-01662-2</ArticleId><ArticleId IdType="pmc">PMC10704838</ArticleId><ArticleId IdType="pubmed">38066589</ArticleId></ArticleIdList></Reference><Reference><Citation>Lemhofer C, Koczulla AR, Meissner W, et al. . [Updated S1 guideline on long/post-COVID: relevant aspects for pain medicine]. Schmerz 2024; 38: 175–182.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10019417</ArticleId><ArticleId IdType="pubmed">36929455</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, et al. . Author correction: long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol 2023; 21: 408. doi:10.1038/s41579-023-00896-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-023-00896-0</ArticleId><ArticleId IdType="pmc">PMC10408714</ArticleId><ArticleId IdType="pubmed">37069455</ArticleId></ArticleIdList></Reference><Reference><Citation>Platz T, Berghem S, Berlit P, et al. . S2k-Leitlinie SARS-CoV-2, COVID-19 und (Früh-) Rehabilitation – eine Kurzfassung mit allen Empfehlungen im Überblick. Rehabilitation (Stuttg) 2023; 62: 76–85. doi:10.1055/a-1844-9984</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/a-1844-9984</ArticleId><ArticleId IdType="pubmed">35913083</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>